KMT2A基因变异所致Wiedemann-Steiner综合征患儿3例的临床特征及遗传学分析

doi:10.6040/j.issn.1671-7554.0.2023.1067

摘要/Abstract

摘要： 目的探讨3例Wiedemann-Steiner综合征(Wiedemann-Steiner syndrome, WSS)患儿的临床特征及遗传学病因,提高对该病的认识。方法回顾性分析2016年8月至2022年7月郑州大学附属儿童医院内分泌遗传代谢科就诊的3例WSS患儿的一般资料、临床特点、生长激素激发试验等实验室检测、垂体磁共振等影像学检查结果,予以重组人生长激素(recombinant human growth hormone, rhGH)治疗,对先证者及家系进行遗传学检测。结果 3例WSS患儿中男2例、女1例,4.8~11.3岁,均因身材矮小就诊,伴智力落后、特殊面容、多毛;病例3生长激素激发试验结果提显示生长激素缺乏,且伴骨龄明显落后;3例患儿垂体磁共振均正常,均予rhGH治疗1~5年,身高分别增加0.9 SD、1 SD、2.2 SD,其中病例3随访至终身高为157.9 cm。基因检测结果示KMT2A基因杂合变异,分别为chr11:118353970-118356519 区域存在 2.5 Kb片段的杂合缺失、c.11081delp.K3694Sfs*3、c.5803-3T>G,3例基因变异均为未报道过的新变异,最终诊断WSS。结论对表现为生长发育迟缓、智力落后、特殊面容、多毛症等患儿需考虑WSS,上述发现拓宽了KMT2A基因的变异谱和临床表型谱。

关键词: Wiedemann-Steiner综合征, 重组人生长激素, KMT2A基因

Abstract: Objective To explore the clinical characteristics and genetic etiology of 3 children with Wiedemann-Steiner syndrome(WSS)and to improve the understanding of the disease. Methods A retrospective analysis was conducted on the general data, clinical characteristics, laboratory tests such as growth hormone stimulation test, and imaging examinations such as pituitary magnetic resonance imaging of three children with WSS who visited Chidrens Hospital Affiliated to Zhengzhou University from August 2016 to July 2022. Recombinant human growth hormone(rhGH)treatment was performed, and genetic testing was conducted on the proband and family. Results Among the 3 patients, 2 were males and 1 was female, aged 4.8 to 11.3 years. All patients were diagnosed with short stature, accompanied by intellectual disability, special facial features, and hirsutism. Growth hormone stimulation test results showed that the case 3 had growth hormone deficiency with significantly delayed bone age. All case showed normal pituitary magnetic resonance imaging, then received rhGH treatment for 1 to 5 years. The height increased by 0.9 SD, 1 SD, and 2.2 SD, respectively, with case 3 followed up to a lifetime height of 157.9 cm. Genetic testing results showed heterozygous mutations in the KMT2A gene. The results showed heterozygous deletions of 2.5 Kb fragments in the chr11:118353970-118356519 region, c.11081delp.K3694Sfs*3, and c.5803-3T>G. All three gene mutations were newly reported. The final diagnoses were WSS. Conclusion For children with delayed growth and development, intellectual disability, special facial features and hirsutism, WSS should be considered. This study broadens the variant spectrum and clinical phenotypic spectrum of the KMT2A gene.

Key words: Wiedemann-Steiner syndrome, Recombinant human growth hormone, KMT2A gene

中图分类号:

R725

王梦琴,张耀东,陈佳佳,张子夏,胡家倩,王曦,赵艺璇,张英娴,卫海燕,陈永兴. KMT2A基因变异所致Wiedemann-Steiner综合征患儿3例的临床特征及遗传学分析[J]. 山东大学学报 (医学版), 2024, 62(6): 76-81.

WANG Mengqin, ZHANG Yaodong, CHEN Jiajia, ZHANG Zixia, HU Jiaqian, WANG Xi, ZHAO Yixuan, ZHANG Yingxian, WEI Haiyan, CHEN Yongxing. Clinical features and genetic analysis of three cases of Wiedemann-Steiner syndrome with KMT2A gene variants[J]. Journal of Shandong University (Health Sciences), 2024, 62(6): 76-81.

参考文献

[1] Steiner CE, Marques AP. Growth deficiency, mental retardation and unusual facies[J]. Clin Dysmorphol, 2000, 9(2): 155-156.
[2] Jones WD, Dafou D, McEntagart M, et al. De novo mutations in MLL cause Wiedemann-Steiner syndrome[J]. Am J Hum Genet, 2012, 91(2): 358-364.
[3] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424.
[4] Yu H, Zhang GJ, Yu SX, et al. Wiedemann-Steiner syndrome: case report and review of literature[J]. Children, 2022, 9(10): 1545. doi:10.3390/children9101545.
[5] Sun Y, Hu GR, Liu HL, et al. Further delineation of the phenotype of truncating KMT2A mutations: the extended Wiedemann-Steiner syndrome[J]. Am J Med Genet A, 2017, 173(2): 510-514.
[6] Li N, Wang YR, Yang Y, et al. Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients[J]. Orphanet J Rare Dis, 2018, 13(1): 178. doi:10.1186/s13023-018-0909-0.
[7] Lin YT, Chen XH, Xie BB, et al. Novel variants and phenotypic heterogeneity in a cohort of 11 Chinese children with Wiedemann-Steiner syndrome[J]. Front Genet, 2023, 14: 1085210. doi:10.3389/fgene.2023.1085210.
[8] Sheppard SE, Campbell IM, Harr MH, et al. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome[J]. Am J Med Genet A, 2021, 185(6): 1649-1665.
[9] Baer S, Afenjar A, Smol T, et al. Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: a study of 33 French cases[J]. Clin Genet, 2018, 94(1): 141-152.
[10] Luo SK, Bi B, Zhang WQ, et al. Three de novo variants in KMT2A(MLL)identified by whole exome sequencing in patients with Wiedemann-Steiner syndrome[J]. Mol Genet Genomic Med, 2021, 9(10): e1798. doi:10.1002/mgg3.1798.
[11] Wang X, Zhang GJ, Lu YJ, et al. Trio-WES reveals a novel de novo missense mutation of KMT2A in a Chinese patient with Wiedemann-Steiner syndrome: a case report[J]. Mol Genet Genomic Med, 2021, 9(1): e1533. doi:10.1002/mgg3.1533.
[12] Di Fede E, Massa V, Augello B, et al. Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes[J]. Eur J Hum Genet, 2021, 29(1): 88-98.
[13] 艾奇,陈云,陈森.KMT2A基因变异所致Wiedemann-Steiner综合征患儿1例的临床特征及遗传学分析[J].中华医学遗传学杂志, 2023, 40(2): 222-225. AI Qi, CHEN Yun, CHEN Sen. Clinical features and genetic analysis of a case of Wiedemann-Steiner syndrome due to variant of KMT2A gene [J]. Chinese Journal of Medical Genetics, 2023, 40(2): 222-225.
[14] Zhang HX, Xiang BW, Chen H, et al. A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia[J]. BMC Med Genet, 2019, 20(1): 38. doi:10.1186/s12881-019-0776-0.
[15] Castiglioni S, Di Fede E, Bernardelli C, et al. KMT2A: umbrella gene for multiple diseases[J]. Genes, 2022, 13(3): 514. doi:10.3390/genes13030514.
[16] Fagerberg L, Hallström BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics[J]. Mol Cell Proteomics, 2014, 13(2): 397-406.
[17] Negri G, Magini P, Milani D, et al. Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders[J]. Hum Genet, 2019, 138(3): 257-269.
[18] 吴若豪,唐文婷,邱坤银,等.一例Wiedemann-Steiner综合征患儿的KMT2A移码变异分析[J].中华医学遗传学杂志, 2022, 39(6): 630-633. WU Ruohao, TANG Wenting, QIU Kunyin, et al. Identification of a novel frameshift variant in the KMT2A gene of a child with Wiedemann-Steiner syndrome[J]. Chinese Journal of Medical Genetics, 2022, 39(6): 630-633.
[19] Reynisdottir T, Anderson KJ, Boukas L, et al. Missense variants causing Wiedemann-Steiner syndrome preferentially occur in the KMT2A-CXXC domain and are accurately classified using AlphaFold2[J]. PLoS Genet, 2022, 18(6): e1010278. doi:10.1371/journal.pgen.1010278.
[20] Buchanan K, Greenup E, Hurst ACE, et al. Case report: 11-ketotestosterone may potentiate advanced bone age as seen in some cases of Wiedemann-Steiner syndrome[J]. Front Endocrinol, 2022, 13: 1004114. doi:10.3389/fendo.2022.1004114.
[21] Mendelsohn BA, Pronold M, Long R, et al. Advanced bone age in a girl with Wiedemann-Steiner syndrome and an exonic deletion in KMT2A(MLL)[J]. Am J Med Genet A, 2014, 164A(8): 2079-2083.
[22] Li X, Song YC. Structure, function and inhibition of critical protein-protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins[J]. J Hematol Oncol, 2021, 14(1): 56. doi:10.1186/s13045-021-01057-7.
[23] Sheppard SE, Quintero-rivera F. Wiedemann-Steiner syndrome [M]. Seattle: University of Washington, 1993.
[24] Stoyle G, Banka S, Langley C, et al. Growth hormone deficiency as a cause for short stature in Wiedemann-Steiner syndrome[J]. Endocrinol Diabetes Metab Case Rep, 2018, 2018: 18-0085. doi:10.1530/EDM-18-0085.
[25] Kim MR, Yoo EG, Rhie S, et al. Growth hormone deficiency in a boy with Wiedemann-Steiner syndrome: a case report and review[J]. Ann Pediatr Endocrinol Metab, 2023, 28(Suppl 1): S25-S28.
[26] Arora V, Puri RD, Bijarnia-Mahay S, et al. Expanding the phenotypic and genotypic spectrum of Wiedemann-Steiner syndrome: first patient from India[J]. Am J Med Genet A, 2020, 182(5): 953-956.
[27] Ikeda D, Chi S, Uchiyama S, et al. Molecular classification and overcoming therapy resistance for acute myeloid leukemia with adverse genetic factors[J]. Int J Mol Sci, 2022, 23(11): 5950. doi:10.3390/ijms23115950.
[28] 上官华坤,胡旭昀,沈亦平,等. KMT2A基因新突变导致Wiedemann-Steiner综合征1例并文献复习[J]. 中华内分泌代谢杂志, 2019, 35(1): 26-31. SHANGGUAN Huakun, HU Xuyun, SHEN Yiping, et al. Wiedemann-Steiner syndrome caused by novel mutation of KMT2A gene: one case report and literature review[J]. Chinese Journal of Endocrinology and Metabolism, 2019, 35(1): 26-31.
[29] 王嘉丽,黄轲,吴蔚,等.KMT2A基因新发变异引起的Wiedemann-Steiner综合征一例[J]. 中华儿科杂志, 2021, 59(6): 516-518. WANG Jiali, HUANG Ke, WU Wei, et al. A case of Wiedemann-Steiner syndrome caused by a novel variation of the KMT2A gene[J]. Chinese Journal of Pediatrics, 2021, 59(6): 516-518.
[30] Feldman HR, Dlouhy SR, Lah MD, et al. The progression of Wiedemann-Steiner syndrome in adulthood and two novel variants in the KMT2A gene[J]. Am J Med Genet A, 2019, 179(2): 300-305.
[31] Ng R, Bjornsson HT, Fahrner JA, et al. Unique profile of academic learning difficulties in Wiedemann-Steiner syndrome[J]. J Intellect Disabil Res, 2023, 67(2): 101-111.
[32] Ng R, Harris J, Fahrner JA, et al. Individuals with Wiedemann-Steiner syndrome show nonverbal reasoning and visuospatial defects with relative verbal skill sparing[J]. J Int Neuropsychol Soc, 2023, 29(5): 512-518.
[33] Ng R, Bjornsson HT, Fahrner JA, et al. Anxiety in Wiedemann-Steiner syndrome[J]. Am J Med Genet A, 2023, 191(2): 437-444.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed